StreetAlpha.app
Home › Stocks › CLOV

Clover Health Investments, Corp. (CLOV)

Healthcare
$4.73
▼ −4.44%
LAST CLOSE · NOV 17

Clover Health sells Medicare Advantage health plans and Clover Assistant, a software platform that helps physicians manage chronic diseases. It last closed at $4.73 on Nov 17, down 4.44% on the day. The average 12-month price target from 2 analysts is $5.75 (+21.6% from the last close), with a high of $6.00 and a low of $5.50. In the past 30 days there were 5 dark pool prints totaling $776K, the largest $202K.

AI Auto Pilots
Is CLOV in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.7B
+54.5% vs a year ago
Net income
$12.4M
0.5% margin
Free cash flow
$132.3M
4.8% margin
Operating margin
0.7%
$18.9M operating income
Balance sheet
Cash & equivalents
$268.1M
At Sep 30
Shareholder equity
$390.9M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.5B$1.5BFY2021FY2022: $1.1B$1.1BFY2022FY2023: $1.3B$1.3BFY2023FY2024: $1.4B$1.4BFY2024FY2025: $1.9B$1.9BFY2025

From CLOV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy · 1 Hold
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy · 1 Hold
2firms
1 Buy1 Hold0 Sell
Only 2 firms rated CLOV in the past 90 days, not enough for a consensus
Average 12-month target
$5.75
▲ 21.6% upside

Based on 2 analysts who set a price target on CLOV in the past 90 days. The average target is $5.75, with a high of $6.00 and a low of $5.50, compared with the last close of $4.73.

$3$4$5$6PAST 109 TRADING DAYS12-MONTH TARGETSHIGH $6AVG $5.75LOW $5.50May 22LAST CLOSE+12 MO$3$4$5$6PAST 109 DAYSTARGETSHIGH $6AVG $5.75LOW $5.50May 22LAST CLOSE+12 MO
Highest target$6.00
Average target$5.75
Lowest target$5.50
Latest rating changes
UBSTarget raised
Nov 6Hold$5 → $5.50
NeedhamInitiated
Oct 28Buy$6
UBSTarget raised
Aug 6Hold$4.75 → $5
Canaccord GenuityTarget raised
Jul 21Buy$4.20 → $5.50
UBSMaintained
Jun 11Hold$4.75
DateFirmActionRatingPrice target
Nov 6UBSTarget raisedHold$5 → $5.50
Oct 28NeedhamInitiatedBuy$6
Aug 6UBSTarget raisedHold$4.75 → $5
Jul 21Canaccord GenuityTarget raisedBuy$4.20 → $5.50
Jun 11UBSMaintainedHold$4.75
Loading…

Technical Analysis

CLOV · as of the Nov 17 close · updated after every close
Uptrend

The stock is 1% above its 20 day and 2% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 51). The nearest support is the 20 day average at $4.70, and the nearest resistance the Pivot at $4.77.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 5.8%/day
Key levels
$5.5952 week high+18.2%
$4.86Pivot R1+2.7%
$4.86Swing high (Oct 28)+2.7%
$4.77Pivot+0.8%
$4.73Last close
$4.7020 day average−0.6%
$4.64Pivot S1−1.9%
$4.6350 day average−2.1%
$4.56100 day average−3.6%
$4.52Swing low (Oct 26)−4.4%
$3.68200 day average−22.2%
$1.5852 week low−66.6%
Indicators
RSI (14)50.81Middle of its rangeNeutral
MACD0.08Above its signal lineBullish
Stochastic63.3Middle of its rangeNeutral
ADX (14)22.8Weak trend
Williams %R-50.5Oversold below −80, overbought above −20Neutral
CCI (20)27.1Oversold below −100, overbought above 100Neutral
Rate of change+10.3%Change over 10 sessionsBullish
ATR (14)$0.28Typical daily range, 5.8% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for CLOV

What happened before

See how CLOV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CLOV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CLOV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in CLOV in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
5
Notional
$776K
Largest print
$202K
Loading…

CLOV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲119 buying vs 85 selling
  • ▲Shares held by funds +7.4%
  • ●Funds holding +1
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding228227+0.4%
In funds' top 1000–
Held by funds–––
New / increased42 / 7743 / 77−0.8%
Reduced / sold out48 / 3754 / 25+7.6%
Put/call ratio0.260.18+44.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CLOV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CLOV is in one of them and how their past CLOV trades turned out.

CLOV in the AI portfolios
Loading…

CLOV News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CLOV in an article yet. Here's the latest on the wider market.

About Clover Health Investments

Clover Health offers Medicare Advantage health plans, including PPO and HMO coverage, mainly for Medicare eligible seniors, with a focus on underserved markets. It also provides Clover Assistant, a software platform that gives physicians patient data and insights to help them identify and manage chronic diseases. Its customers include seniors who enroll in its plans and the physicians in its provider networks. The company is based in Jersey City, New Jersey.

Headquarters
Jersey City, NJ